Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited.

Revitalist Releases Benefits Program Giving Access To All for Ketamine Therapies Changing the Narrative of Mental Health to Risk Mitigation | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – November 25, 2024) – Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) (the “Company“) announces release of

November 25, 2024

Brain Aging Trajectories Identified in Post-Mortem Tissue

Two distinct pathways of brain aging emerged in a cellular analysis of post-mortem brain tissue. One trajectory led to Alzheimer’s disease, the other to an

September 4, 2024

Small Pharma: Positive Top-line Data from SPL026 SSRI Drug Interaction Study

Small Pharma (CVE: DMT)(OTCMKTS: DMTTF), a biotechnology company recently acquired by Cybin Inc. and specializing in brief psychedelic-assisted therapies for mental health disorders, has unveiled encouraging findings

September 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.